SCHEMBL1065962

SCHEMBL1065962

CCCCCCCCCCCC[CH]C(C)O

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 3/20 0.44
MEN1 O00255 4/20 0.44
KMT2A Q03164 4/20 0.44
CYP3A4 P08684 1/20 0.44
SPHK1 Q9NYA1 3/20 0.41
MAPT P10636 3/20 0.41
THRB P10828 3/20 0.41
GMNN O75496 2/20 0.41
LMNA P02545 2/20 0.41
GLA P06280 2/20 0.41
POLB P06746 2/20 0.41
CETP P11597 2/20 0.41
MAPK1 P28482 2/20 0.41
CXCR5 P32302 2/20 0.41
CCR6 P51684 2/20 0.41
BLM P54132 2/20 0.41
UBE2N P61088 2/20 0.41
SPHK2 Q9NRA0 2/20 0.41
CYP2D6 P10635 2/20 0.41
ALDH1A1 P00352 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9858047 1.00 TSHR (0.44) TSHRMEN1KMT2ACYP3A4SPHK1
SCHEMBL3930548 1.00 TSHR (0.44) TSHRMEN1KMT2ACYP3A4SPHK1
SCHEMBL12500451 1.00 TSHR (0.44) TSHRMEN1KMT2ACYP3A4SPHK1
SCHEMBL2070551 1.00 TSHR (0.44) TSHRMEN1KMT2ACYP3A4SPHK1
SCHEMBL9576760 1.00 TSHR (0.44) TSHRMEN1KMT2ACYP3A4SPHK1
SCHEMBL9009715 1.00 TSHR (0.44) TSHRMEN1KMT2ACYP3A4SPHK1
SCHEMBL28334079 1.00 TSHR (0.44) TSHRMEN1KMT2ACYP3A4SPHK1
SCHEMBL944919 1.00 TSHR (0.44) TSHRMEN1KMT2ACYP3A4SPHK1
SCHEMBL4867923 0.97
SCHEMBL25413991 0.93 FAAH (0.50) MEN1KMT2ACYP3A4MAPTGMNN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 53 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3003718-B1 SUCCESSIVELY PEELABLE COEXTRUDED POLYMER FILM WITH EMBEDDED ANTIMICROBIAL LAYER(S) 3M INNOVATIVE PROPERTIES CO (US) 2021-12-29 EP disclosed
EP-3905985-A1 ANTIMICROBIAL DENTAL APPLIANCE 3M Innovative Properties Company (US) 2021-11-10 EP disclosed
US-10940106-B2 Biodegradable copolymers for cosmetic use INTERCOS S.P.A. (IT) 2021-03-09 US disclosed
US-10918618-B2 Methods of reducing microbial contamination 3M INNOVATIVE PROPERTIES COMPANY (US) 2021-02-16 US disclosed
WO-2020141444-A1 ANTIMICROBIAL DENTAL APPLIANCE 3M INNOVATIVE PROPERTIES COMPANY (US) 2020-07-09 WO disclosed
US-10682830-B2 Successively peelable coextruded polymer film with embedded antimicrobial layer(s) 3M INNOVATIVE PROPERTIES COMPANY (US) 2020-06-16 US disclosed
US-20190159999-A1 BIODEGRADABLE COPOLYMERS FOR COSMETIC USE INTERCOS S.P.A. (IT) 2019-05-30 US disclosed
EP-2497459-B1 Methods of reducing microbial contamination 3M INNOVATIVE PROPERTIES CO (US) 2019-04-24 EP disclosed
EP-3452009-A1 BIODEGRADABLE COPOLYMERS FOR COSMETIC USE Intercos S.p.A. (IT) 2019-03-13 EP disclosed
EP-3025704-B1 METHODS OF REDUCING MICROBIAL CONTAMINATION 3M INNOVATIVE PROPERTIES CO (US) 2019-01-16 EP disclosed
EP-1898900-A2 ANTIMICROBIAL COMPOSITIONS COMPRISING ESTERS OF HYDROXYCARBOXYLIC ACIDS 3M Innovative Properties Company (US) 2008-03-19 EP disclosed
EP-1861085-A1 ANTIVIRAL COMPOSITIONS AND METHODS OF USE 3M Innovative Properties Company (US) 2007-12-05 EP disclosed
EP-1858506-A2 METHODS OF TREATING EAR INFECTIONS 3M Innovative Properties Company (US) 2007-11-28 EP disclosed
EP-1858482-A2 METHODS OF REDUCING MICROBIAL CONTAMINATION 3M Innovative Properties Company (US) 2007-11-28 EP disclosed
US-20060229364-A1 Antiviral compositions and methods of use 3M INNOVATIVE PROPERTIES COMPANY 2006-10-12 US disclosed
WO-2006099359-A2 METHODS OF REDUCING MICROBIAL CONTAMINATION 3M INNOVATIVE PROPERTIES COMPANY (US) 2006-09-21 WO disclosed
WO-2006099358-A2 ANTIMICROBIAL COMPOSITIONS COMPRISING ESTERS OF HYDROXYCARBOXYLIC ACIDS 3M INNOVATIVE PROPERTIES COMPANY (US) 2006-09-21 WO disclosed
WO-2006099374-A1 ANTIVIRAL COMPOSITIONS AND METHODS OF USE 3M INNOVATIVE PROPERTIES COMPANY (US) 2006-09-21 WO disclosed
WO-2006099325-A2 METHODS OF TREATING EAR INFECTIONS 3M INNOVATIVE PROPERTIES COMPANY (US) 2006-09-21 WO disclosed
EP-0324391-A2 Method for the formation of high-contrast images KONICA CORPORATION (JP) 1989-07-19 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10940106-B2 Biodegradable copolymers for cosmetic use LAGE3, LMTK2, LSS TSHR 1442/4885MEN1 2373/4885KMT2A 3878/4885
US-10918618-B2 Methods of reducing microbial contamination LPO, CAT, UNG TSHR 4354/4885MEN1 3051/4885KMT2A 4294/4885
US-20190159999-A1 BIODEGRADABLE COPOLYMERS FOR COSMETIC USE LAGE3, LMTK2, LSS TSHR 1442/4885MEN1 2373/4885KMT2A 3878/4885
US-10682830-B2 Successively peelable coextruded polymer film with embedded antimicrobial layer(s) PUF60, PCBP1, CD99 TSHR 4631/4885MEN1 2207/4885KMT2A 3414/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.